30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Reimbursement / Regulatory

Artoss Gains FDA Clearance of NanoBone SBX Putty for Standalone Use in Fusion -

Artoss gained FDA 510(k) clearance to market NanoBone® SBX Putty for standalone use in posterolateral spinal fusion. NanoBone was tested without addition of autograft or bone marrow aspirate in an animal model and found to be equivalent to the gold standard of autograft in fusion rate. (Artoss, Inc., 4/24/19)